Skip to main content
. Author manuscript; available in PMC: 2018 Jan 17.
Published in final edited form as: Circulation. 2016 Nov 9;135(3):251–263. doi: 10.1161/CIRCULATIONAHA.116.024611

Table 2.

Relationship of LPA rs3798220, rs10485774 and rs9459571 to Lp(a), apolipoprotein(a) isoforms and OxPL-apoB.

Black

rs3798220 TT (N = 1765) TC (N= 27) CC (N = 0) P-Value
Lp(a), nmol/L 79.3 (43.8-132.2) 49.1 (13.5-122.6) - 0.15
OxPL-apoB, RLU 6507 (3510-11416) 4305 (2501-8733) - 0.11
Major apolipoprotein(a) isoform, #KIV repeats 23.0 (20-26) 23.0 (21-33) - 0.042
White

TT (N = 985) TC (N= 43) CC (N = 1)

Lp(a), nmol/L 25.9 (9.5-58.1) 187.3 (113.4-229.1) 197.1 (-) <0.001
OxPL-apoB, RLU 2963 (2217-4701) 12493 (8521-16202) 13222 (-) <0.001
Major apolipoprotein(a) isoform, #KIV repeats 24.5 (19-29) 17.0 (17-19) 17.0 (-) <0.001
Hispanic

TT (N = 343) TC (N= 212) CC (N = 41)

Lp(a), nmol/L 25.2 (10.2-61.0) 18.8 (8.1-36.6) 13.2 (6.4-22.9) <0.001
OxPL-apoB, RLU 2873 (2145-4567) 2586 (1972-3360) 2445 (1777-2901) <0.001
Major apolipoprotein(a) isoform, #KIV repeats 25.0 (20-30) 30.25 (24-34) 33.0 (31.5-34) <0.001
Black

rs10485774 AA (N = 1759) AG (N= 33) GG (N = 0) P-Value

Lp(a), nmol/L 77.9 (43.4-132.1) 207.0 (117-261.9) - <0.001
OxPL-apoB, RLU 6314 (3473-11300) 11854 (6397-17005) - <0.001
Major apolipoprotein(a) isoform, #KIV repeats 23.0 (20-26) 17 (16-17.5) - <0.001
White

AA (N = 882) AG (N= 139) GG (N = 8)

Lp(a), nmol/L 21.2 (8.1-41.8) 141.4 (108.4-172.3) 219.6 (205.6-276.9) <0.001
OxPL-apoB, RLU 2826 (2134-3895) 7949 (5496-10745) 12534 (8792-16924) <0.001
Major apolipoprotein(a) isoform, #KIV repeats 25.5 (21-29) 17.0 (16-18) 17.25 (16.1-17.5) <0.001
Hispanic

AA (N = 563) AG (N= 31) GG (N = 2)

Lp(a), nmol/L 19.6 (8.1-40.7) 151.7 (102.6-198.2) 151.3 (-) <0.001
OxPL-apoB, RLU 2602 (2046-3530) 7966 (4773-12056) 8583 (-) <0.001
Major apolipoprotein(a) isoform, #KIV repeats 28.0 (22-32) 17.0 (16-17) 17.0 (-) <0.001
Black
rs9459571 CC (N = 1202) CG (N= 547) GG (N = 43) P-Value

Lp(a), nmol/L 73.8 (40.6-121.9) 94.4 (50.8-153.4) 97.0 (62.2-186.6) <0.001
OxPL-apoB, RLU 5502 (3247-9864) 8602 (4241-14223) 8032 (5052-17154) <0.001
Major apolipoprotein(a) isoform, #KIV repeats 22.5 (20-26) 24.0 (20-27) 24.0 (19-24) 0.008
White
CC (N = 1025) CG (N= 3) GG (N = 1)

Lp(a), nmol/L 26.7 (10.1-68.7) 89.8 (-) 35.8 (-) 0.38
OxPL-apoB, RLU 3015 (2233-5286) 8223 (-) 1952 (-) 0.43
Major apolipoprotein(a) isoform, #KIV repeats 24.0 (19-29) 26.0 (-) 27.0 (-) 0.85
Hispanic

CC (N = 575) CG (N= 20) GG (N = 1)

Lp(a), nmol/L 20.6 (8.2-43.7) 76.4 (32.6-146.6) 507 (-) <0.001
OxPL-apoB, RLU 2656 (2053-3674) 6508 (2993-11918) 18675 (-) <0.001
Major apolipoprotein(a) isoform, #KIV repeats 28.0 (21-32) 21.5 (6508) 14 (-) 0.003

Black
rs1801693 AA (N = 1326) AG (N= 391) GG (N = 26) P-Value

Lp(a), nmol/L 84.3 (49.5-134.7) 55.7 (30.6-116.5) 44.2 (12.0-98.0) <0.001
OxPL-apoB, RLU 7066 (3884-11613) 4482 (2893-9923) 3836 (2459-9549) <0.001
Major apolipoprotein(a) isoform, #KIV repeats 23.0 (20-26) 24.0 (20-28) 25.0 (19.75-32) <0.001
White
AA (N = 474) AG (N= 434) GG (N = 98)

Lp(a), nmol/L 28.5 (11.7-80.1) 23.8 (8.6-57.1) 24.9 (4.2-108.2) 0.025
OxPL-apoB, RLU 3104 (2250-5773) 2958 (2229-4635) 3127 (2134-8486) 0.29
Major apolipoprotein(a) isoform, #KIV repeats 23.25 (18-29) 25.0 20-28 24.25 (18-29) 0.068
Hispanic

AA (N = 192) AG (N= 266) GG (N = 126)

Lp(a), nmol/L 29.5 (13.4-78.5) 19.6 (6.8-40.6) 16.4 (7.8-36.8) <0.001
OxPL-apoB, RLU 2898 (2172-3587) 2739 (2049-3587) 2520 (1850-3570) 0.016
Major apolipoprotein(a) isoform, #KIV repeats 24.0 (19-28) 28.0 (23-33) 31.0 (25.38-33.63) <0.001
Black
rs41272110 TT (N = 1704) TG (N= 78) GG(N = 2) P-Value

Lp(a), nmol/L 79.4 (43.9-132.8) 59.3 (31.4-124.8) 60.5 (-) 0.33
OxPL-apoB, RLU 6509 (3521-11428) 4769 (2960-10707) 6317 (-1) 0.37
Major apolipoprotein(a) isoform, KIV repeats 23.0 (20-26.5) 21.5 (18-25) 22.5 (-) 0.071
White
TT (N = 746) TG (N= 258) GG(N = 14)

Lp(a), nmol/L 26.4 (7.3-76.6) 27.2 (13.7-58.4) 24.9 (13.4-106.7) 0.51
OxPL-apoB, RLU 3097 (265-5576) 2920 (2096-5036) 2575 (2170-4421) <0.001
Major apolipoprotein(a) isoform, #KIV repeats 26.0 (19-29.5) 20.25 (18-25.63) 19.0 (18-20) 0.56
Hispanic

TT (N = 490) TG (N= 99) GG(N = 4)

Lp(a), nmol/L 20.6 (7.1-47.7) 23.5 (14.1-33.9) 21.4 (5.4-35.0) 0.47
OxPL-apoB, RLU 2774 (2056-3962) 2519 (2050-3468) 2566 (2264-3117) 0.62
Major apolipoprotein(a) isoform, #KIV repeats 28.5 (23-33) 20.0 (19-26) 19.5(19-22) <0.001

Black
G+1/inKIV-8A GG(N = 1673) GA N(= 98) AA(N = 4) P-Value

Lp(a), nmol/L 78.9 (43.5-131.5) 77.6(50.8-153.4) 70.4 (30.8-91.2) 0.90
OxPL-apoB, RLU 6481 (3520-11305) 5845 (3036-13624) 5956 (2972-14026) 0.99
Major apolipoprotein(a) isoform, #KIV repeats 23.0 (20-26) 22.75 (20-26) 25.5 (19.5-31.5) 0.60
White
GG (N = 962) GA(N= 52) AA(N = 3)

Lp(a), nmol/L 26.4 (10.1-68.9) 32.3 (9.0-92.2) 37.5 () 0.66
OxPL-apoB, RLU 3020 (2239-5296) 2984 (2262-5648) 1812 (-) 0.63
Major apolipoprotein(a) isoform, #KIV repeats 24.0 (19-29) 23.5 (17.25-27.75) 19.0 (-) 0.30
Hispanic

GG (N = 558) GA (N= 28) AA(N = 1)

Lp(a), nmol/L 21.1 (8.7-45.4) 24.8 (7.5-70.3) 5.1 (-) 0.72
OxPL-apoB, RLU 2720 (2070-3730) 2593 (2134-4741) 1708 (-) 0.71
Major apolipoprotein(a) isoform, #KIV repeats 27.0 (21-32) 28.0 (19.5-31.0) 34.0 (-) 0.43

Values are given as median (IQR).

HHS Vulnerability Disclosure